Our advanced molecular biology, genomics, and serology laboratory is equipped with cutting-edge technologies, including the Illumina NextSeq™ 1000, to drive high-impact research on infectious diseases like malaria, tuberculosis, and antimicrobial resistance. By combining robust field sample processing, high-quality DNA/RNA extraction, and comprehensive PCR workflows with downstream next-generation sequencing and basic bioinformatics analysis, we provide precision genomic data for disease surveillance and epidemiological studies. Additionally, our specialized serology workflows leverage validated immunological assays, ELISA antibody testing, and immune response profiling to evaluate host defenses and champion improved maternal and neonatal health outcomes.
Sequencing
Our molecular biology and genomics laboratory utilizes state-of-the-art pathogen detection, characterization, and genomic analysis technologies to drive research on malaria, tuberculosis, antimicrobial resistance, and other infectious diseases of critical public health importance. Central to these capabilities is our high-throughput Illumina NextSeq™ 1000 next-generation sequencing platform, which enables comprehensive genomic analyses-including whole-genome sequencing, targeted and amplicon sequencing, RNA sequencing (RNA-Seq), metagenomics, and microbial genomic surveillance. By facilitating the rapid generation of high-quality genomic data, this infrastructure directly supports advanced scientific research, real-time outbreak investigations, and actionable precision public health initiatives.
ELISA Antibody Testing
We perform Enzyme-Linked Immunosorbent Assays (ELISA) for the detection and quantification of pathogen-specific antibodies, antigens, cytokines, and other biomarkers. These assays support vaccine evaluation, seroprevalence studies, and immunological research. QuantiFERON®-TB Gold Plus Testing. We perform the QuantiFERON®-TB Gold Plus assay, an interferon-gamma release assay (IGRA) used to assess immune responses to Mycobacterium tuberculosis. This assay supports tuberculosis research, latent TB infection studies, epidemiological investigations, and immune monitoring in high-risk populations
Antigen/Antibody Detection
Our laboratory utilizes a range of immunological assays for the qualitative and quantitative detection of pathogen antigens and antibodies. These methods support infectious disease diagnosis, exposure assessment, surveillance, and monitoring of immune status.
Serology
Our serology platform utilizes the Luminex system to detect and quantify antibodies, antigens, cytokines, and other immune biomarkers from a single sample. This multiplex technology enables high-throughput, sensitive, and accurate immune profiling, supporting infectious disease research, vaccine studies, biomarker discovery, and host immune response analysis.
